Sale!

PGAM2 Gene Glycogen storage disease type 10 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PGAM2 gene is associated with Glycogen Storage Disease Type X (also known as Glycogen Storage Disease Type 10), a metabolic disorder that affects muscle function. This condition is characterized by a deficiency in the enzyme phosphoglycerate mutase, which is crucial for glycogen metabolism in muscle tissues. Symptoms can include muscle cramps, exercise intolerance, and myoglobinuria, potentially leading to kidney damage in severe cases.

Genetic testing for mutations in the PGAM2 gene is a critical step in diagnosing Glycogen Storage Disease Type X. This test helps in confirming the diagnosis, understanding the disease’s progression, and planning appropriate management and treatment strategies for affected individuals.

At DNA Labs UAE, a specialized test for the PGAM2 gene related to Glycogen Storage Disease Type 10 is available. The cost of this genetic test is 4400 AED. Conducting this test at DNA Labs UAE ensures accurate diagnosis through state-of-the-art genetic testing technologies, provided by a team of experts in genetic disorders. This facilitates early and effective intervention, improving the quality of life for individuals with this condition.

Description

PGAM2 Gene Glycogen Storage Disease Type 10 Genetic Test

Test Name: PGAM2 Gene Glycogen storage disease type 10 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PGAM2 Gene Glycogen storage disease type 10 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Glycogen storage disease type 10.

Test Details: The PGAM2 gene is associated with Glycogen Storage Disease Type 10 (GSD10), which is a rare genetic disorder characterized by the accumulation of glycogen in certain tissues, particularly in the liver and muscles. Next-Generation Sequencing (NGS) is a high-throughput genetic testing method that can be used to analyze multiple genes simultaneously. In the context of GSD10, an NGS genetic test would involve sequencing the PGAM2 gene to identify any variations or mutations that may be present. This type of genetic testing can be used to confirm a diagnosis of GSD10 in individuals with symptoms suggestive of the disorder. It can also be used for carrier testing in individuals who have a family history of GSD10 or for prenatal testing in families at risk of having a child with the condition. The results of an NGS genetic test for GSD10 can help healthcare providers determine the appropriate management and treatment options for individuals with the condition. It can also provide valuable information for genetic counseling and family planning purposes.

Test Name	PGAM2 Gene Glycogen storage disease type 10 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PGAM2 Gene Glycogen storage disease type 10 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycogen storage disease type 10
Test Details	The PGAM2 gene is associated with Glycogen Storage Disease Type 10 (GSD10), which is a rare genetic disorder characterized by the accumulation of glycogen in certain tissues, particularly in the liver and muscles. Next-Generation Sequencing (NGS) is a high-throughput genetic testing method that can be used to analyze multiple genes simultaneously. In the context of GSD10, an NGS genetic test would involve sequencing the PGAM2 gene to identify any variations or mutations that may be present. This type of genetic testing can be used to confirm a diagnosis of GSD10 in individuals with symptoms suggestive of the disorder. It can also be used for carrier testing in individuals who have a family history of GSD10 or for prenatal testing in families at risk of having a child with the condition. The results of an NGS genetic test for GSD10 can help healthcare providers determine the appropriate management and treatment options for individuals with the condition. It can also provide valuable information for genetic counseling and family planning purposes.